![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: KCNMB2 |
Gene summary for KCNMB2 |
![]() |
Gene information | Species | Human | Gene symbol | KCNMB2 | Gene ID | 10242 |
Gene name | potassium calcium-activated channel subfamily M regulatory beta subunit 2 | |
Gene Alias | KCNMB2 | |
Cytomap | 3q26.32 | |
Gene Type | protein-coding | GO ID | GO:0001508 | UniProtAcc | B5BNW5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10242 | KCNMB2 | HTA12-15-2 | Human | Pancreas | PDAC | 9.49e-17 | 1.18e+00 | 0.2315 |
10242 | KCNMB2 | HTA12-16-2 | Human | Pancreas | PDAC | 3.89e-04 | 9.90e-01 | 0.0535 |
10242 | KCNMB2 | HTA12-23-1 | Human | Pancreas | PDAC | 4.37e-30 | 1.95e+00 | 0.3405 |
10242 | KCNMB2 | HTA12-25-1 | Human | Pancreas | PDAC | 3.43e-28 | 1.65e+00 | 0.313 |
10242 | KCNMB2 | HTA12-26-1 | Human | Pancreas | PDAC | 4.07e-55 | 2.16e+00 | 0.3728 |
10242 | KCNMB2 | HTA12-29-1 | Human | Pancreas | PDAC | 6.72e-118 | 1.97e+00 | 0.3722 |
10242 | KCNMB2 | HTA12-30-1 | Human | Pancreas | PDAC | 5.68e-12 | 1.86e+00 | 0.3671 |
10242 | KCNMB2 | HTA12-32-1 | Human | Pancreas | PDAC | 1.71e-15 | 2.03e+00 | 0.3624 |
10242 | KCNMB2 | HTA12-9-1 | Human | Pancreas | PDAC | 2.52e-07 | 5.73e-01 | 0.1532 |
10242 | KCNMB2 | HTA12-9-2 | Human | Pancreas | PDAC | 1.65e-02 | 3.13e-01 | 0.0835 |
10242 | KCNMB2 | HTA12-9-3 | Human | Pancreas | PDAC | 1.07e-02 | 5.73e-01 | 0.2045 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |